Spire Biomedical Introduces New Clot-Resistant Dialysis Catheter at ASN Renal Week 2006 Conference; Spire Biomedical Offers FDA-Approved Decathlon Gold(TM) Coated Catheter

SAN DIEGO--(BUSINESS WIRE)--Nephrologists from throughout the world will gather at the San Diego Convention Center the week of November 14-19 for the American Society of Nephrology’s (ASN) 39th Annual “Renal Week 2006” Meeting. Among the nearly 200 exhibitors featured at this year’s conference is Spire Biomedical, Inc., a Bedford, Massachusetts-based manufacturer of medical devices and provider of advanced surface modification services. With special expertise in catheter technology for use by the Nephrology community, Spire will introduce an innovative new product at the ASN conference: the Decathlon Gold End-Point™ Bonded heparin coated catheter, which received clearance earlier this year from the U.S. Food and Drug Administration (FDA) for use in long-term hemodialysis treatment.